Knott David M Jr »

Iovance Biotherapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.6M 1.6M 3.51
2022-09-30 $312k 33k 9.57
2022-06-30 $360k 33k 11.04
2022-03-31 $510k 31k 16.66
2021-12-31 $382k 20k 19.08

More positions owned by Knott David M Jr

Alphabet Inc-Cl C Common (GOOG)
Apollo Global Management Common (APO)
Syndax Pharmaceutical Common (SNDX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
Xeris Biopharma Holdings Common (XERS)
JPMorgan Chase & Co. Common (JPM)
Iovance Biotherapeutics Common (IOVA)
LPL Financial Holdings Common
Janus Henderson AAA CLO ETF Common (JAAA)
Alkermes Common (ALKS)
Travere Therapeutics Common (TVTX)
Cogent Biosciences Common (COGT)
Viridian Therapeutics Common (VRDN)
Agios Pharmaceutical Common (AGIO)

View all positions for Knott David M Jr

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Invenomic Capital Management
Bank of America Corporation
D. E. Shaw & Co
Susquehanna International
Palo Alto Investors

View all funds holding Iovance Biotherapeutics